InvestorsHub Logo

Meowza

07/05/23 11:45 AM

#411627 RE: CaptBeer #411626

Okay that makes more sense. If 4 pills is the starting point, then statins truly were spayed from the CVR stack and your spelling was intentional.

ziploc_1

07/05/23 12:48 PM

#411630 RE: CaptBeer #411626

Mochida and Amarin agreed to 'collaborate' on EPA products in 2018...

Then, two years later Amarin issued this PR...QUOTE "We exercised certain rights under the agreement, resulting in payments of $1.0 million in each of January 2020 and December 2020, respectively, to Mochida."

We do not know...
1. What royalties in the agreement, if any, would be due to Mochida for selling MND-2119 products in the U.S.?
2. Would this agreement cover an Amarin combo product with MND-2110 plus a statin?
3. Would Amarin need FDA approval for either an MND-2119 drug or a combo drug with MND-2119?...If so....
4. Would this 'collaboration' agreement survive a sale of Amarin to a BP?